do glp 1 agonists have cardiovascular benefit A Comprehensive Review of the Role of GLP-1 in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure GLP-1 medications are known for

Antithrombotic Effects GLP-1 agonists reduce cardiovascular events through several mechanisms previously summarized to include improved glycemic control, weight loss, lowering blood pressure, lipid lowering, reduced atherogenesis, attenuated vascular inflammation, improved endothelial cell function, vasodilation, and direct cardiovascular protective effects [88, 89]

The drug may no longer be manufactured or available in the U.S

Further studies should explore if prokinetics can be given to patients who are shown to have RGC on ultrasound and then be re-scanned to see if sedation can proceed

Interestingly, selective knockdown of GLP-1Rs in the supramammillary nucleus led to anxiolytic response, which was observed only in females [87]

Clinicians should exercise caution until larger, carefully planned prospective trials elucidate these correlations, particularly when administering GLP-1 RAs for prolonged periods of time in individuals that are already at risk for colorectal cancers